pharmacie et médicaments – Déremboursement d'un médicament contre l'arthrose

This written question asks the government about the delisting of a medication used to treat osteoarthritis. It seeks clarification on the reasons behind this decision and its impact on patients. The question concerns patients suffering from osteoarthritis and the accessibility of their treatment. It highlights potential issues for individuals relying on this specific medication.